Actinium-225 trading represents a specialized niche in healthcare investment, driven by cancer treatment demand and limited to grams of annual global production.
Discover how prediction markets price astatine’s extreme scarcity and 8.1-hour half-life, with 2026 medical breakthroughs driving volatility in the rarest natural element trading.